A multi-pronged intervention reduced prior authorization delays and denials for patients treated in a radiation oncology department.

“Heading into 1Q25, we also believe BPMC could be seen as an attractive target for strategic partnerships, which could boost shares,” JP Morgan writes. With Ayvakit’s launch being a major focus for ...

To address this issue, Dr. Peng introduced three new technologies, including “arteriovenous ultrasound for dialysis patients,” significantly reducing the diagnosis and treatment time and costs for ...